243 related articles for article (PubMed ID: 35435082)
1. Radiomics analysis of ultrasound to predict recurrence of hepatocellular carcinoma after microwave ablation.
Wu JP; Ding WZ; Wang YL; Liu S; Zhang XQ; Yang Q; Cai WJ; Yu XL; Liu FY; Kong D; Zhong H; Yu J; Liang P
Int J Hyperthermia; 2022; 39(1):595-604. PubMed ID: 35435082
[TBL] [Abstract][Full Text] [Related]
2. A radiomics-based model can predict recurrence-free survival of hepatocellular carcinoma after curative ablation.
Peng W; Jiang X; Zhang W; Hu J; Zhang Y; Zhang L
Asian J Surg; 2023 Jul; 46(7):2689-2696. PubMed ID: 36351862
[TBL] [Abstract][Full Text] [Related]
3. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Contrast-Enhanced Ultrasound Radiomics for Hepatocellular Carcinoma Recurrence Prediction After Thermal Ablation.
Ma QP; He XL; Li K; Wang JF; Zeng QJ; Xu EJ; He XQ; Li SY; Kun W; Zheng RQ; Tian J
Mol Imaging Biol; 2021 Aug; 23(4):572-585. PubMed ID: 33483803
[TBL] [Abstract][Full Text] [Related]
5. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.
Li SQ; Su LL; Xu TF; Ren LY; Chen DB; Qin WY; Yan XZ; Fan JX; Chen HS; Liao WJ
World J Gastroenterol; 2023 Jul; 29(26):4186-4199. PubMed ID: 37475840
[TBL] [Abstract][Full Text] [Related]
6. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
[TBL] [Abstract][Full Text] [Related]
7. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
9. Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection.
Zhang L; Hu J; Hou J; Jiang X; Guo L; Tian L
Abdom Radiol (NY); 2021 Aug; 46(8):3845-3854. PubMed ID: 33733337
[TBL] [Abstract][Full Text] [Related]
10. Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma.
Zhu HB; Zheng ZY; Zhao H; Zhang J; Zhu H; Li YH; Dong ZY; Xiao LS; Kuang JJ; Zhang XL; Liu L
Diagn Interv Radiol; 2020 Sep; 26(5):411-419. PubMed ID: 32490826
[TBL] [Abstract][Full Text] [Related]
11. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma.
Yang Y; Zhou Y; Zhou C; Ma X
Eur J Surg Oncol; 2022 May; 48(5):1068-1077. PubMed ID: 34862094
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
[TBL] [Abstract][Full Text] [Related]
13. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
[TBL] [Abstract][Full Text] [Related]
15. Predicting hepatocellular carcinoma early recurrence after ablation based on magnetic resonance imaging radiomics nomogram.
Yang X; Yuan C; Zhang Y; Li K; Wang Z
Medicine (Baltimore); 2022 Dec; 101(52):e32584. PubMed ID: 36596081
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
Yang X; Yuan C; Zhang Y; Wang Z
Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
[TBL] [Abstract][Full Text] [Related]
17. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
18. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
[TBL] [Abstract][Full Text] [Related]
19. Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.
Song D; Wang Y; Wang W; Wang Y; Cai J; Zhu K; Lv M; Gao Q; Zhou J; Fan J; Rao S; Wang M; Wang X
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3757-3767. PubMed ID: 33839938
[TBL] [Abstract][Full Text] [Related]
20. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
